INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer
17:57
From Approval to Practice: Managing Side Effects of Antibody Drug Conjugates (ADC) in Cancer
22:28
How to Approach and Treat Pancreatic Cancer
23:22
The use of Immunotherapy in unresectable Hepatocellular Carcinoma (HCC)
58:06
HDX Dataset Deep Dive with the Internal Displacement Monitoring Centre
25:24
How to Approach to Endometrial Cancer from Community Oncology Perspective
1:22:26
JOAN SEBASTIAN y MARCO ANTONIO SOLIS 30 GRANDES EXITOS || JOAN SEBASTIAN y SOLIS SUS MEJORES
1:30:57
Advancements in Care for Metastatic Breast Cancer
26:19